Sonomed, Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 2445 Harmony Pl, La Crescenta, CA 91214 Phone: 818-957-3957 Fax: 818-957-3958 |
Evlyn Avanessian, Md, Inc Family Medicine Medicare: Medicare Enrolled Practice Location: 3628 Foothill Blvd, La Crescenta, CA 91214 Phone: 818-296-9601 Fax: 818-296-9602 |
2 See Optometry Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 3115 Foothill Blvd Ste D, La Crescenta, CA 91214 Phone: 818-832-4646 Fax: 818-368-9898 |
A Foothill Acupuncture And Health. Inc. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 3430 Foothill Blvd Ste B, La Crescenta, CA 91214 Phone: 818-541-9751 |
Arbol Acupuncture Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 2620 Foothill Blvd Ste A, La Crescenta, CA 91214 Phone: 213-909-4035 |
Faster Care Clinics Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 3800 La Crescenta Ave, #207, La Crescenta, CA 91214 Phone: 818-957-9595 Fax: 818-957-8484 |
News Archive
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
Chinese health officials this week announced the country will move forward in May with a ban on smoking in all indoor public spaces "in an effort to shield the world's most populous nation ... from the harmful effects of the habit," Reuters reports.
Health and Human Services (HHS) Secretary Kathleen Sebelius announced six winners in the HHSinnovates program today in a ceremony at HHS headquarters, saying all the entries "show a vibrant culture of innovation" within the department.
Cytheris SA and the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute with its Central Operations and Statistical Center headquartered at Fred Hutchinson Cancer Research Center, Seattle, Washington, today announced the selection of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, as one of the first immunotherapeutic agents proposed for initial clinical trials at network institutions.
The American Chemical Society (ACS) invites news media to attend another in a continuing series of discussions with leading scientists, economists, and politicians on a wide range of timely scientific topics, including energy, nuclear terrorism, food safety, and climate and energy policy.
› Verified 7 days ago